No significant difference in the total number of NK cells and lymphocyte subsets, the absolute number (or percentage) of CD8+ T, CD4+ T or B cells was found between patients with moderate COVID‐19 and control patients (Figure 2A,C–E, Data S1). This evidence concerns the gene CD8A and COVID-19.